|
EP0906104A4
(en)
*
|
1996-03-25 |
2003-12-10 |
Lilly Co Eli |
PAIN TREATMENT PROCESS
|
|
ZA977967B
(en)
*
|
1996-09-23 |
1999-03-04 |
Lilly Co Eli |
Combination therapy for treatment of psychoses
|
|
ES2151828B1
(es)
|
1998-07-10 |
2001-08-16 |
Esteve Labor Dr |
Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor.
|
|
WO2000028980A2
(en)
*
|
1998-11-13 |
2000-05-25 |
Eli Lilly And Company |
Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
|
|
US6280763B1
(en)
|
1999-05-10 |
2001-08-28 |
Pierce Management, Llc |
Apparatus and method for transdermal delivery of bupropion
|
|
DE19924929C2
(de)
*
|
1999-05-31 |
2001-05-31 |
Elegene Gmbh |
Neues Verfahren zur Untersuchung der Eignung eines Materials als Pharmakon
|
|
PL196996B1
(pl)
|
1999-07-01 |
2008-02-29 |
Upjohn Co |
Zastosowanie optycznie czystej (S,S)-reboksetyny lub jej dopuszczalnej farmaceutycznie soli do wytwarzania leku
|
|
US20040115133A1
(en)
*
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
|
US20060083691A1
(en)
*
|
2000-05-10 |
2006-04-20 |
Wermeling Daniel P |
Intranasal opioid compositions, delivery devices and methods of using same
|
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
|
DE10112798A1
(de)
*
|
2001-03-16 |
2002-10-02 |
Elegene Gmbh |
Vorrichtung und Verfahren zur automatischen Erzeugung einer Wärmevermeidungsreaktion von Nematoden oder ähnlichen Lebewesen
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
|
SE0102855D0
(sv)
*
|
2001-08-27 |
2001-08-27 |
Astrazeneca Ab |
Method of treatment
|
|
WO2003022261A1
(en)
|
2001-09-13 |
2003-03-20 |
Miller Kenneth E |
Method of alleviating pain
|
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
|
US6635675B2
(en)
*
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
|
JP2006505489A
(ja)
*
|
2002-02-08 |
2006-02-16 |
アボット・ラボラトリーズ |
精神分裂病の治療のための併用療法
|
|
CA2475763A1
(en)
*
|
2002-02-12 |
2003-08-21 |
Cypress Bioscience, Inc. |
Methods of treating attention deficit/hyperactivity disorder (adhd)
|
|
DE60330322D1
(de)
*
|
2002-03-26 |
2010-01-14 |
Teva Pharma |
Arzneimittel-mikroteilchen
|
|
MXPA04011529A
(es)
*
|
2002-04-24 |
2005-08-15 |
Cypress Bioscience Inc |
Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension.
|
|
US20040101481A1
(en)
*
|
2002-11-26 |
2004-05-27 |
Alexza Molecular Delivery Corporation |
Acute treatment of headache with phenothiazine antipsychotics
|
|
AU2003227521A1
(en)
*
|
2002-05-30 |
2003-12-19 |
Neurosearch A/S |
Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain
|
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
|
AU2003284005B2
(en)
*
|
2002-10-03 |
2009-12-17 |
Forest Laboratories Holdings Limited |
Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
|
|
ATE420647T1
(de)
|
2002-11-26 |
2009-01-15 |
Alexza Pharmaceuticals Inc |
Verwendung von loxapine für die herstellung eines mittels zur behandlung von schmerz
|
|
AR042806A1
(es)
|
2002-12-27 |
2005-07-06 |
Otsuka Pharma Co Ltd |
Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
|
|
CN1726039B
(zh)
|
2002-12-27 |
2010-08-18 |
大塚制药株式会社 |
用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂
|
|
US20040234914A1
(en)
|
2003-05-21 |
2004-11-25 |
Alexza Molecular Delivery Corporation |
Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
|
|
WO2004105690A2
(en)
*
|
2003-05-23 |
2004-12-09 |
Cypress Bioscience, Inc. |
Treatment of chronic pain associated with drug or radiation therapy
|
|
DK1626721T3
(en)
*
|
2003-05-23 |
2017-01-23 |
Otsuka Pharma Co Ltd |
CARBOSTYRIL DERIVATIVES AND Mood Stabilizers for the Treatment of Mood Disorders
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
JP4964593B2
(ja)
*
|
2003-09-25 |
2012-07-04 |
セノメド バイオサイエンシーズ，エルエルシー |
神経学的病状の治療用のテトラヒドロインドロン誘導体
|
|
US20050107439A1
(en)
*
|
2003-11-10 |
2005-05-19 |
Helton David R. |
Composition and method for treating emesis
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
MY147767A
(en)
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
US7581540B2
(en)
|
2004-08-12 |
2009-09-01 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
|
MX2007014613A
(es)
|
2005-05-20 |
2008-04-02 |
Johnson & Johnson |
Procedimiento para la preparacion de derivados de sulfamida.
|
|
UA97349C2
(uk)
*
|
2005-09-08 |
2012-02-10 |
Х. Луннбэк А/С |
Стійкі тверді склади сертиндолу
|
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
|
EP1795609A1
(en)
|
2005-12-06 |
2007-06-13 |
Sanofi-Aventis Deutschland GmbH |
Method for the diagnosis and treatment of cardiovascular diseases
|
|
US8551986B2
(en)
*
|
2005-12-08 |
2013-10-08 |
The Mclean Hospital Corporation |
Treatment of sequelae of psychiatric disorders
|
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
AR058389A1
(es)
|
2005-12-19 |
2008-01-30 |
Janssen Pharmaceutica Nv |
Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
|
|
US8716231B2
(en)
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
US8497298B2
(en)
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US8691867B2
(en)
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
AU2007253814A1
(en)
|
2006-05-19 |
2007-11-29 |
Janssen Pharmaceutica N.V. |
Co-therapy for the treatment of epilepsy
|
|
WO2008112661A2
(en)
|
2007-03-09 |
2008-09-18 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
WO2008128166A1
(en)
*
|
2007-04-13 |
2008-10-23 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
|
|
WO2009062134A1
(en)
*
|
2007-11-09 |
2009-05-14 |
Cenomed Biosciences, Llc |
Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
|
|
US20090264443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
David Helton |
Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
|
|
PE20110060A1
(es)
|
2008-06-23 |
2011-01-31 |
Janssen Pharmaceutica Nv |
Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
|
|
US8815939B2
(en)
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
|
US8697735B2
(en)
|
2008-07-25 |
2014-04-15 |
Bionevia Pharmaceuticals, Inc. |
Solid forms of epalrestat
|
|
EA023435B1
(ru)
|
2008-09-06 |
2016-06-30 |
Бионевия Фармасьютикалс, Инк. |
Фармацевтическая композиция, включающая новый холиновый сокристалл эпалрестата
|
|
EA027136B1
(ru)
|
2012-07-02 |
2017-06-30 |
Пнб Веспер Лайф Сайенс Пвт Лимитед |
Новые лиганды холецистокининовых рецепторов
|
|
WO2014078568A1
(en)
|
2012-11-14 |
2014-05-22 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
|
TWI734665B
(zh)
|
2013-12-24 |
2021-08-01 |
維吉尼亞聯邦大學 |
氧化膽固醇硫酸鹽（ｏｃｓ）之用途
|
|
US20190117637A1
(en)
*
|
2016-06-13 |
2019-04-25 |
Board Of Regents Of The University Of Texas System |
Pharmaceutical compositions and methods for treatment of pain
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
KR102852740B1
(ko)
|
2018-02-02 |
2025-08-29 |
알렉스자 파마스티칼즈, 인크. |
전기적 응축 에어로졸 디바이스
|
|
WO2020212951A1
(en)
|
2019-04-17 |
2020-10-22 |
Compass Pathfinder Limited |
Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
|
|
US12389955B2
(en)
*
|
2021-10-22 |
2025-08-19 |
Nike, Inc. |
Garment adjusting system
|
|
US11977085B1
(en)
|
2023-09-05 |
2024-05-07 |
Elan Ehrlich |
Date rape drug detection device and method of using same
|